Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Lisata Therapeutics (LSTA) over the last 3 years, with Q3 2025 value amounting to $26000.0.

  • Lisata Therapeutics' Depreciation and Depletion rose 1304.35% to $26000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $99000.0, marking a year-over-year increase of 1000.0%. This contributed to the annual value of $100000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Lisata Therapeutics reported Depreciation and Depletion of $26000.0 as of Q3 2025, which was up 1304.35% from $26000.0 recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' Depreciation and Depletion ranged from a high of $60000.0 in Q2 2023 and a low of $11000.0 during Q4 2023
  • Over the past 3 years, Lisata Therapeutics' median Depreciation and Depletion value was $26000.0 (recorded in 2025), while the average stood at $28000.0.
  • Examining YoY changes over the last 5 years, Lisata Therapeutics' Depreciation and Depletion showed a top increase of 9090.91% in 2024 and a maximum decrease of 5500.0% in 2024.
  • Over the past 3 years, Lisata Therapeutics' Depreciation and Depletion (Quarter) stood at $11000.0 in 2023, then soared by 90.91% to $21000.0 in 2024, then increased by 23.81% to $26000.0 in 2025.
  • Its Depreciation and Depletion stands at $26000.0 for Q3 2025, versus $26000.0 for Q2 2025 and $26000.0 for Q1 2025.